STRO
Sutro Biopharma·NASDAQ
--
--(--)
--
--(--)
3.85 / 10
Netural
Analysts issue a unanimous Buy recommendation, yet their past performance is –6.3% average return with 0% win rate. Fund flow is positive (overall inflow ratio 0.51) and rated good, though small and large block flows turn negative.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-20
InstitutionCitizens
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of STRO?
- STRO holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 3.85/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
